Skip to content

Perinatal Mental Health Study (PMHS) India

Perinatal Mental Health Study (PMHS): a Cohort and Validation Study in Two Low-income Settings in India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05485701
Acronym
PMHS
Enrollment
2332
Registered
2022-08-03
Start date
2022-09-01
Completion date
2026-08-31
Last updated
2023-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, PTSD, Somatization, Suicidal Ideation

Keywords

Perinatal, Post-partum, Antenatal, Low- and middle-income country, India, Common mental disorders, Screening, Validation, Prevalence, Risk factor

Brief summary

The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.

Detailed description

The purpose of this observational study is to assess the mental health of perinatal women living in two low-income settings in India. The first phase will explore women's awareness of mental illness and acceptability of screening for mental disorders. The second phase will be a validation study, during which the psychometric properties of screening tools will be assessed against a gold standard. The third stage will comprise a cohort study, during which the prevalence of and risk factors for mental disorders among perinatal and non-perinatal women will be established.

Interventions

DIAGNOSTIC_TESTScreening tools for common mental disorders

A number of screening tools will be administered which will establish the likelihood of depression, anxiety, PTSD, somatisation and suicidality.

Sponsors

National Institute of Mental Health and Neuro Sciences, India
CollaboratorOTHER
Dr. Rajendra Prasad Government Medical College
CollaboratorOTHER
University of Oxford
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

For Phase 1 (qualitative study) and Phase 2 (validation study): Pregnant women: * Aged 18 to 45 years * Currently pregnant (any trimester) * Willing and able to give informed consent Post-partum women: * Aged 18 to 45 years * Currently post-partum (between 1-12 months postpartum) * Willing and able to give informed consent Non-perinatal women: * Aged 18 to 45 years * Not currently pregnant and not given birth in the past 12 months * Willing and able to give informed consent For Phase 3 (prospective cohort study): Perinatal women: * Aged 18 to 45 years * In early pregnancy (estimated gestational age \<20 weeks) at recruitment * Not planning to relocate for the duration of the study period * Willing and able to give informed consent * Expressed a willingness to continue to participate for the four planned visits Non-perinatal women: * Aged 18 to 45 years * Not currently pregnant and not given birth in the last 12 months * Not planning to relocate for the duration of the study period * Willing and able to give informed consent * Expressed a willingness to continue to participate for the four planned visits

Exclusion criteria

The participant may not enter the study if: * They have an acutely severe psychiatric illness which impairs their ability to take part in the study * They are not willing or able to provide informed consent Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.

Design outcomes

Primary

MeasureTime frameDescription
Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal womenSeptember 2023 - August 2024During the cohort study, prevalence and incidence of mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.
Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disordersTo be completed by August 2022These will be themes emerging from focus groups with women around awareness of perinatal mental disorders and acceptability of screening.
Phase 2: Psychometric properties of screening tools for common mental disordersSeptember 2022 - August 2023The psychometric properties (sensitivity, specificity, area under the receiver operating curve, optimal cut-off and accuracy) of eight screening tools in Kannada and Hindi will be established among three groups of women: pregnant, post-partum and non-perinatal.
Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal womenSeptember 2023 - August 2024During the cohort study, risk factors associated with mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.

Countries

India

Contacts

Primary ContactGracia Fellmeth, DPhil
gracia.fellmeth@ndph.ox.ac.uk00441865289745

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026